BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $62 at RBC Capital
RBC Capital analyst Luca Issi lowered ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
